Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Interest & Investment Income (2022 - 2025)

Historic Interest & Investment Income for Maravai Lifesciences Holdings (MRVI) over the last 4 years, with Q3 2025 value amounting to $2.8 million.

  • Maravai Lifesciences Holdings' Interest & Investment Income fell 6044.41% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.1 million, marking a year-over-year decrease of 4765.84%. This contributed to the annual value of $27.4 million for FY2024, which is 116.85% down from last year.
  • Maravai Lifesciences Holdings' Interest & Investment Income amounted to $2.8 million in Q3 2025, which was down 6044.41% from $3.0 million recorded in Q2 2025.
  • Maravai Lifesciences Holdings' 5-year Interest & Investment Income high stood at $7.5 million for Q4 2023, and its period low was $2.3 million during Q4 2022.
  • For the 4-year period, Maravai Lifesciences Holdings' Interest & Investment Income averaged around $5.5 million, with its median value being $6.4 million (2023).
  • In the last 5 years, Maravai Lifesciences Holdings' Interest & Investment Income skyrocketed by 21903.34% in 2023 and then tumbled by 6044.41% in 2025.
  • Over the past 4 years, Maravai Lifesciences Holdings' Interest & Investment Income (Quarter) stood at $2.3 million in 2022, then surged by 219.03% to $7.5 million in 2023, then dropped by 19.08% to $6.0 million in 2024, then tumbled by 53.66% to $2.8 million in 2025.
  • Its last three reported values are $2.8 million in Q3 2025, $3.0 million for Q2 2025, and $3.2 million during Q1 2025.